Fabio
88 lines
5.1 KiB
Markdown
88 lines
5.1 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "INSPECT program."
|
||
description: "Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes."
|
||
jurisdiction: "us/states/in"
|
||
legislature: "Indiana General Assembly"
|
||
session: "2026"
|
||
identifier: "SB 262"
|
||
citation: "Indiana SB 262 (2026)"
|
||
classification: ["bill"]
|
||
subjects: ["AGENCIES; Department of Health (IDOH)", "AGENCIES; Family and Social Services Administration (FSSA)", "AGENCIES; Professional Licensing Agency (PLA)", "HEALTH CARE FACILITIES; Pharmacies", "HEALTH CARE PROFESSIONALS; Pharmacists", "HEALTH; Prescription Drugs and Medications"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Ed Charbonneau", "Lori Goss-Reaves", "Michael Crider"]
|
||
version_count: 4
|
||
action_count: 22
|
||
vote_count: 3
|
||
first_action: "2026-01-08"
|
||
last_action: "2026-03-05"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/4ff6780a-ae30-42b2-a9e6-8cdebe3eddf6"
|
||
source_url: "https://api.iga.in.gov/2026/bills/sb0262"
|
||
source_hash: "52c38448dc3043432220d37b9cc9452a108f5ebf7368a23438537710d44b200e"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-in"]
|
||
---
|
||
|
||
# Indiana SB 262 (2026) — INSPECT program.
|
||
|
||
Sets forth the circumstances in which a dispenser is not required to transmit certain information to the INSPECT program (program). Requires an opioid treatment program to, before reporting patient information to the program, comply with federal regulations in obtaining patient consent. Allows the board of pharmacy to disclose prescription drug monitoring program data to a representative of the Indiana department of health and the office of the secretary of family and social services for specified purposes.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Engrossed Senate Bill (H)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/124/2026/senate/bills/SB0262/SB0262.03.ENGS.pdf)
|
||
2. **Enrolled Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/124/2026/senate/bills/SB0262/SB0262.05.ENRH.pdf)
|
||
3. **Introduced Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/124/2026/senate/bills/SB0262/SB0262.01.INTR.pdf)
|
||
4. **Senate Bill (S)** (committee substitute) — [source](https://iga.in.gov/pdf-documents/124/2026/senate/bills/SB0262/SB0262.04.COMH.pdf)
|
||
|
||
## Votes
|
||
|
||
- SB 262 - Goss-Reaves - 3rd Reading — **94–0** (pass) · lower
|
||
- SB 262 - Crider — **47–0** (pass) · upper
|
||
- SB 262 - Crider - 3rd Reading — **48–0** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Ed Charbonneau — primary (person)
|
||
- Lori Goss-Reaves — primary (person)
|
||
- Michael Crider — primary (person)
|
||
- Brad Barrett — cosponsor (person)
|
||
- Cindy Ledbetter — cosponsor (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2026-01-08** First reading: referred to Committee on Health and Provider Services `reading-1, referral-committee`
|
||
- **2026-01-08** Authored by Senator Crider
|
||
- **2026-01-15** Committee report: amend do pass, adopted `committee-passage`
|
||
- **2026-01-22** Senator Charbonneau added as second author
|
||
- **2026-01-26** Amendment #2 (Crider) prevailed; voice vote `amendment-passage`
|
||
- **2026-01-26** Second reading: amended, ordered engrossed `reading-2`
|
||
- **2026-01-28** Cosponsors: Representatives Barrett, Ledbetter
|
||
- **2026-01-28** Third reading: passed; Roll Call 127: yeas 48, nays 0 `passage, reading-3, reading-3`
|
||
- **2026-01-28** House sponsor: Representative Goss-Reaves
|
||
- **2026-01-29** Referred to the House `referral`
|
||
- **2026-02-02** First reading: referred to Committee on Public Health `reading-1, referral-committee`
|
||
- **2026-02-17** Committee report: amend do pass, adopted `committee-passage`
|
||
- **2026-02-19** Second reading: ordered engrossed `reading-2`
|
||
- **2026-02-23** Third reading: passed; Roll Call 312: yeas 94, nays 0 `passage, reading-3, reading-3`
|
||
- **2026-02-24** Motion to concur filed `filing`
|
||
- **2026-02-24** Returned to the Senate with amendments `receipt`
|
||
- **2026-02-25** Senate concurred with House amendments; Roll Call 287: yeas 47, nays 0
|
||
- **2026-02-27** Signed by the President of the Senate `passage`
|
||
- **2026-03-05** Signed by the Governor `executive-signature`
|
||
- **2026-02-27** Signed by the President Pro Tempore `passage`
|
||
- **2026-03-05** Public Law 133 `became-law`
|
||
- **2026-02-27** Signed by the Speaker `passage`
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/4ff6780a-ae30-42b2-a9e6-8cdebe3eddf6`. Confidence: reported (aggregated from official Indiana legislature records).
|
||
|